Becattini C - Search Results

1

Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W. Becattini C, et al. Chest. 2006 Jul;130(1):172-5. doi: 10.1378/chest.130.1.172. Chest. 2006. PMID: 16840398

2

Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.

Vedovati MC, Mosconi MG, Isidori F, Agnelli G, Becattini C. Vedovati MC, et al. Among authors: becattini c. J Thromb Thrombolysis. 2020 Feb;49(2):251-258. doi: 10.1007/s11239-019-01956-0. J Thromb Thrombolysis. 2020. PMID: 31520364

3

Clinical and economic aspects of managing venous thromboembolism in the outpatient setting.

Agnelli G, Becattini C. Agnelli G, et al. Among authors: becattini c. Semin Hematol. 2001 Apr;38(2 Suppl 5):58-66. doi: 10.1016/s0037-1963(01)90099-x. Semin Hematol. 2001. PMID: 11449344 Review.

4

Risk factors for adverse short-term outcome in patients with pulmonary embolism.

Becattini C, Agnelli G. Becattini C, et al. Thromb Res. 2001 Sep 15;103(6):V239-44. doi: 10.1016/s0049-3848(01)00291-2. Thromb Res. 2001. PMID: 11567661 Review.

5

Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.

Agnelli G, Becattini C, Kirschstein T. Agnelli G, et al. Among authors: becattini c. Arch Intern Med. 2002 Dec 9-23;162(22):2537-41. doi: 10.1001/archinte.162.22.2537. Arch Intern Med. 2002. PMID: 12456225

6

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators. Agnelli G, et al. Among authors: becattini c. Ann Intern Med. 2003 Jul 1;139(1):19-25. doi: 10.7326/0003-4819-139-1-200307010-00008. Ann Intern Med. 2003. PMID: 12834314 Clinical Trial.

7

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.

Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: becattini c. J Thromb Haemost. 2003 Aug;1(8):1730-3. doi: 10.1046/j.1538-7836.2003.00293.x. J Thromb Haemost. 2003. PMID: 12911585

8

A prospective study on cardiovascular events after acute pulmonary embolism.

Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, Poggio R, Imberti D, Ageno W, Pogliani E, Porro F, Casazza F. Becattini C, et al. Eur Heart J. 2005 Jan;26(1):77-83. doi: 10.1093/eurheartj/ehi018. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15615803 Clinical Trial.

9

Long-term therapy of pulmonary embolism.

Agnelli G, Becattini C. Agnelli G, et al. Among authors: becattini c. Ital Heart J. 2005 Oct;6(10):824-9. Ital Heart J. 2005. PMID: 16270474 Review.

10

Initial treatment of venous thromboembolism.

Becattini C, Agnelli G, Emmerich J, Bura A, Weitz JI. Becattini C, et al. Thromb Haemost. 2006 Sep;96(3):242-50. doi: 10.1160/TH06-05-0260. Thromb Haemost. 2006. PMID: 16953263 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results